GDA-301

N/A

Report date: 2024/11/15 11:25:32

Base Information

Drug NameGDA-301

Drug Alias NameGDA301

ClassificationCell and gene therapy > Gene therapyCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > Natural killer cell therapy

Mechanisms of ActionInterleukin-15 stimulants

TargetsInterleukin-15

Therapy Area/IndicationsHematologic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryIsrael

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesGamida Cell Ltd

China Registration ClassN/A

Develop Information

Active CompaniesGamida Cell Ltd

Inactive CompaniesN/A

Active IndicationsHematologic Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A